Tadalafil NOBEL 5 mg

Tadalafil NOBEL 5 mg is a medicine authorised by Swissmedic under authorisation number 69811. The authorisation holder is NOBEL Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 29 July 2025 and the authorisation is limited until 28 July 2030. ATC code G04BE08 places the medicine in the group Urologicals.

  • Dispensing category B
  • Authorisation number 69811
  • ATC G04BE08
  • Synthetic medicines
Authorisation data
Authorisation number69811
NameTadalafil NOBEL 5 mg
Full nameTadalafil NOBEL 5 mg, Filmtabletten
Authorisation holderNOBEL Pharma Schweiz AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeG04BE08
First authorisation29 July 2025
Authorisation validity28 July 2030
Strengths
No.NameDispensing categoryAuthorisation date
1Tadalafil NOBEL 5 mg, FilmtablettenB29 July 2025
2Tadalafil NOBEL 10 mg, FilmtablettenB29 July 2025
3Tadalafil NOBEL 20 mg, FilmtablettenB29 July 2025

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
114Tablette(n)G04BE0805.99.0.B
228Tablette(n)G04BE0805.99.0.B
384Tablette(n)G04BE0805.99.0.B
44Tablette(n)G04BE0805.99.0.B
512Tablette(n)G04BE0805.99.0.B
64Tablette(n)G04BE0805.99.0.B
78Tablette(n)G04BE0805.99.0.B
812Tablette(n)G04BE0805.99.0.B
924Tablette(n)G04BE0805.99.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Tadalafil NOBEL 5 mg authorised in Switzerland?

Yes. Tadalafil NOBEL 5 mg is authorised by Swissmedic under authorisation number 69811, data as of 01 September 2026. The authorisation is limited until 28 July 2030.

Which dispensing category does Tadalafil NOBEL 5 mg have?

Tadalafil NOBEL 5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Tadalafil NOBEL 5 mg?

The authorisation holder is NOBEL Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com